Zealand Pharma A/S
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ZLDPF | KLRA | ENTX | GPCR | MAZE | LXRX | |
|---|---|---|---|---|---|---|
| Market cap | 2.26B | 1.46B | 465.88M | 1.50B | 1.53B | 676.33M |
| P/E (TTM) | 5.6 | — | — | — | — | — |
| Forward P/E | -29.3 | -2.6 | -4.9 | -10.0 | -8.5 | -8.0 |
| Price/book | 0.9 | 1.3 | 18.2 | 1.1 | 3.4 | 3.9 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | −52.51% | −56.73% | +8.50% | −24.36% | −7.46% | 0.00% |
| Today | 0.00% | −3.93% | −3.25% | −5.00% | +0.18% | −7.88% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ZLDPF news ›Royalty Pharma plc and Zealand Pharma A/S Enter into Rusfertide Funding Agreement for $100 Million
Royalty Pharma plc announced an agreement for $100 million in funding to Zealand Pharma A/S in exchange for Zealand Pharma A/S?s economics related to rusfertide , a potential first-in-class therapy... Royalty Pharma plc announced an…
Member Spotlight: Zealand Pharma A/S
Massachusetts Biotechnology Council Zealand Pharma is a biotechnology company transforming metabolic health so millions of people can live without limits. With the opening of its new research hub at 35 CambridgePark Drive, Zealand Pharma…
Analyzing Zealand Pharma A/S (OTCMKTS:ZLDPF) & Fractyl Health (NASDAQ:GUTS)
Posted by Michael Walen on Oct 14th, 2026 Zealand Pharma A/S (OTCMKTS:ZLDPF – Get Free Report) and Fractyl Health (NASDAQ:GUTS – Get Free Report) are both healthcare companies, but which is the superior business? We will contrast the two…
Zealand Pharma A/S and Generate Biomedicines Inc. Enter Collaboration and License Agreement to Develop Protein Therapeutics Engineered with Ai for Metabolic Diseases
Zealand Pharma A/S announced a multi-target strategic collaboration with Generate Biomedicines Inc. . Under the collaboration, the companies intend to design and develop multispecific protein... Zealand Pharma A/S announced a multi-target…
Zealand Pharma A/S : Insider Transactions
Follow insider transactions on Zealand Pharma A/S in real time. Filter by importance or transaction type and analyze the history on MarketScreener. Insider Transactions Zealand Pharma A/S Biotechnology & Medical Research Latest insider…
All Transcripts on Zealand Pharma A/S (ZEAL)
Find all the latest transcripts on Zealand Pharma A/S Transcripts Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01, 2026 at 07:54 am EDT All financial news and data…
Zealand Pharma A/S: Official Announcements - Stock Market News
Find the latest press releases and official documents published by Zealand Pharma A/S on MarketScreener. Press Releases Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much weight October 01,…
Zealand Pharma A/S Stock (ZEAL) - Quote Nasdaq Copenhagen
Zealand Pharma A/S is specialized in the research and development of peptide drugs mainly for the treatment of diabetes, rare diseases and obesity. At the end of 2025, the Group had a portfolio of 8 products in clinical development…
Zealand Pharma A/S: Relative Strength Chart - Stock Nasdaq Copenhagen
Compare Zealand Pharma A/S with the company of your choice via a Relative Strength chart. Real-time ZEAL price, Nasdaq Copenhagen stock exchange Relative Strength Chart Zealand Pharma A/S Biotechnology & Medical Research All financial news…
Zealand Pharma A/S: News in other languages | ZEAL | DK0060257814
Zealand Pharma A/S: News, information and stories for Zealand Pharma A/S | Nasdaq Copenhagen: ZEAL | Nasdaq Copenhagen Other languages Zealand Pharma A/S Biotechnology & Medical Research Zealand Pharma: weight loss fails to carry much…
From articles in the 4Search news index.
In the news
Mentioned with
People in the coverage
Most coverage from
-
marketscreener.com9
-
massbio.org1
-
themarketsdaily.com1
Finance and business coverage in the 4Search news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 11 articles, not a forecast.